Gilead Sciences Acquires CymaBay Therapeutics
Gilead Sciences acquired CymaBay Therapeutics for $4.3B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Gilead Sciences
- Acquired Company
- CymaBay Therapeutics
- Price
- $4.3B
- Acquisition Type
- Merger
- Announced
- February 12, 2024
Canonical: https://fsome.com/acquisitions/gilead-sciences-acquires-cymabay-therapeutics-8238491 · For the full deal terms, timeline, and press references, please enable JavaScript.